{"id":2003562,"date":"2023-08-17T11:58:02","date_gmt":"2023-08-17T15:58:02","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/novo-nordisk-study-sees-wegovy-lowering-heart-attacks-by-1-5-million-over-10-years\/"},"modified":"2023-08-17T12:02:03","modified_gmt":"2023-08-17T16:02:03","slug":"novo-nordisk-study-sees-wegovy-lowering-heart-attacks-by-1-5-million-over-10-years","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/novo-nordisk-study-sees-wegovy-lowering-heart-attacks-by-1-5-million-over-10-years\/","title":{"rendered":"Wegovy from Novo Nordisk may prevent 1.5 million heart attacks in a decade."},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"&quot;\"><div class=\"counts mashsbcount\">26<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fnovo-nordisk-study-sees-wegovy-lowering-heart-attacks-by-1-5-million-over-10-years%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=2003562&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><h2>The Revolutionary Weight Loss Drug That Could Save Lives<\/h2>\n<p>The\u2063 groundbreaking \u200c<a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/alexei-navalny-goes-on-hunger-strike-russian-prison-service-responds\/\" title=\"Alexei Navalny Goes On Hunger Strike, Russian Prison Service Responds\">weight loss<\/a> drug Wegovy has\u2063 the potential \u2062to prevent a \u2063staggering 1.5\u200b million heart attacks in the United States over the next decade, according \u200bto a\u200d <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/reliable-power-during-the-energy-transition-requires-natural-gas\/\" title=\"Reliable Power During The Energy Transition Requires Natural Gas\">recent study conducted<\/a> by scientists at the University of California, Irvine.<\/p>\n<p>&#8220;This is a game-changer in the world of \u2063obesity and cardiovascular medicine,&#8221; said\u2064 Nathan\u2063 Wong, the lead author of\u200d the study \u200cand director of\u2062 the Heart Disease Prevention Program at UCI School of Medicine. &#8220;We now have a weight control therapy that not \u2063only helps with weight loss but also significantly reduces the\u2064 risk of cardiovascular events, going beyond \u2064its original focus on the diabetes population.&#8221;<\/p>\n<h3>Impressive Results and Promising Outlook<\/h3>\n<p>The researchers based their findings \u200don a 2021 study of \u2064semaglutide, the active ingredient \u2064in Wegovy. The study revealed that obese or overweight patients lost an astonishing 15%\u200d of \u200dtheir body weight while taking the drug.<\/p>\n<p>Estimating that around 93 million \u2063obese or overweight adults in the U.S. would be eligible for semaglutide treatment\u2063 in the next \u2062decade, the study suggests that Wegovy could potentially reduce the \u2063number\u2063 of obese patients by up to 43\u2064 million.<\/p>\n<p>Based on \u200bthis data, the \u2064researchers projected that \u200cthe decrease in the obese population could lead\u2064 to an 18% reduction in cardiovascular disease, potentially preventing 1.5 million cardiovascular incidents.<\/p>\n<h3>Support and\u2062 Validation<\/h3>\n<p>The UCI study \u200dreceived financial support from Novo \u2063Nordisk, the\u2063 manufacturer of semaglutide, as disclosed in the \u2064research funding\u2063 statement.<\/p>\n<p>These findings align with <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/novo-nordisk-study-sees-wegovy-lowering-heart-attacks-by-1-5-million-over-10-years\/\" title=\"Wegovy from Novo Nordisk may prevent 1.5 million heart attacks in a decade.\">independent research published\u200d earlier<\/a>\u200b this month. A worldwide, multiyear study conducted by the research firm SELECT showed that patients on Wegovy were 20%\u200d less likely to experience adverse cardiovascular events, such as \u200dstrokes or heart attacks.<\/p>\n<p>Martin Holst Lange, <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/flashback-former-ag-barr-initiated-spying-program-on-americans-back-in-1992\/\" title=\"FLASHBACK: Former AG Barr Initiated Spying Program on Americans Back in 1992\">executive vice president<\/a> for development at \u200bNovo, hailed the worldwide study as &#8220;a landmark trial&#8221; and emphasized the potential\u2062 of \u200dsemaglutide \u200c2.4 \u2063mg to\u2064 revolutionize the treatment of obesity.<\/p>\n<h3>Success and \u2062Growth<\/h3>\n<p>Novo Nordisk has\u200d <a href=\"https:\/\/www.conservativenewsdaily.net\/breaking-news\/mcauliffe-staffer-says-fck-off-to-reporter-asking-questions\/\" title=\"McAuliffe Staffer Says \u2018F*ck Off\u2019 to Reporter Asking Questions\">made significant strides<\/a> this year with its semaglutide products. Wegovy, approved by the Food\u2064 and Drug Administration at\u2063 a 2.4 mg dose for weight loss, \u200dand Ozempic, FDA approved \u2063for insulin-dependent Type \u20642 diabetes with a semaglutide dose ranging between 0.5 mg and 2 mg.<\/p>\n<p>In the second quarter earnings\u200b report, Novo revealed profits exceeding $3.5 billion, with sales surpassing expectations by 3%.<\/p>\n<h3>Continued Research and Safety Concerns<\/h3>\n<p>Health regulatory boards in \u200bthe\u200c European Union and the United Kingdom are currently investigating\u2063 semaglutide and similar medications for potential risks\u200b of suicidal or self-harm thoughts. It is important to note that \u2063these risks are not listed as side \u2063effects of either Wegovy or \u200bOzempic.<\/p>\n<p>In\u2062 addition, a lawsuit was filed against Novo \u200dand \u2062U.S.-based competitor Eli Lilly this month \u2064for stomach \u2064paralysis caused by both Ozempic and Lilly&#8217;s Mounjaro, which is also used to treat\u2063 Type 2 \u200bdiabetes.<\/p>\n<p>Both Novo and\u200b Lilly have emphasized their commitment to patient\u2064 safety\u200b and taking \u2062these matters seriously.<\/p>\n<p><a href=\"https:\/\/www.washingtonexaminer.com\">Click here<\/a> to read more from The Washington Examiner.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>researcher of the study. Wegovy, a widely used weight loss medication, has the potential to avert 1.5 million heart attacks in the US within a decade, as per University of California, Irvine scientists. Nathan Wong, the study&#8217;s lead researcher, hailed it as a significant breakthrough in the field of obesity and cardiovascular medicine.<\/p>\n","protected":false},"author":1,"featured_media":2003563,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[538],"tags":[],"class_list":["post-2003562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-washington-examiner"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2003562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=2003562"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/2003562\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/2003563"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=2003562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=2003562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=2003562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}